110 related articles for article (PubMed ID: 8545299)
1. Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
Laidlaw ST; Reilly JT; Suvarna SK
Postgrad Med J; 1995 Oct; 71(840):639. PubMed ID: 8545299
[No Abstract] [Full Text] [Related]
2. Proton pump inhibitor therapy in chemotherapy-induced pancreatitis.
Fettah A; Yarali N; Bayram C; Kirsaclioglu CT; Tunc B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):660-1. PubMed ID: 23652874
[No Abstract] [Full Text] [Related]
3. Recurrent mercaptopurine-induced acute pancreatitis: a rare complication of chemotherapy for acute lymphoblastic leukemia in children.
Willert JR; Dahl GV; Marina NM
Med Pediatr Oncol; 2002 Jan; 38(1):73-4. PubMed ID: 11835247
[No Abstract] [Full Text] [Related]
4. 6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.
De Abreu RA; Lambooy LH; Ahment K; Brouwer C; Keizer-Garritsen JJ; Bokkerink JP; Trijbels FJ
Adv Exp Med Biol; 2000; 486():271-5. PubMed ID: 11783498
[No Abstract] [Full Text] [Related]
5. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
6. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.
Tanaka Y; Manabe A; Nakadate H; Kondoh K; Nakamura K; Koh K; Utano T; Kikuchi A; Komiyama T
Leuk Res; 2012 May; 36(5):560-4. PubMed ID: 22200619
[TBL] [Abstract][Full Text] [Related]
7. Heritage-specific mechanisms for cancer adverse reactions: one gene does not explain the world.
Knepper TC; McLeod HL
J Clin Oncol; 2015 Apr; 33(11):1230-1. PubMed ID: 25753435
[No Abstract] [Full Text] [Related]
8. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.
Ando M; Ando Y; Hasegawa Y; Sekido Y; Shimokata K; Horibe K
Pharmacogenetics; 2001 Apr; 11(3):269-73. PubMed ID: 11337943
[No Abstract] [Full Text] [Related]
9. Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia.
Uminski K; Khalife R; Fulcher J; Duffett L; Wang TF; Tinmouth A
Ann Hematol; 2022 May; 101(5):1137-1139. PubMed ID: 34611720
[No Abstract] [Full Text] [Related]
10. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
Stuckert AJ; Schafer ES; Bernhardt MB; Baxter P; Brackett J
Leuk Lymphoma; 2020 May; 61(5):1246-1249. PubMed ID: 31842647
[No Abstract] [Full Text] [Related]
11. [Association between polymorphism of NUDT15 gene and hepatotoxicity induced by 6-MP in children with acute lymphoblastic leukemia].
Wang X; Wang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1258-1261. PubMed ID: 34839520
[TBL] [Abstract][Full Text] [Related]
12. Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia.
Higgerson K; Flatt T
J Pediatr Hematol Oncol; 2023 May; 45(4):e514-e517. PubMed ID: 37027323
[TBL] [Abstract][Full Text] [Related]
13. Mercaptopurine-induced fever: hypersensitivity reaction in a patient with acute lymphoblastic leukemia.
Chen LJ; Nightingale G; Baer MR
Pharmacotherapy; 2010 Jan; 30(1):113. PubMed ID: 20030482
[TBL] [Abstract][Full Text] [Related]
14. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
Tulstrup M; Frandsen TL; Abrahamsson J; Lund B; Vettenranta K; Jonsson OG; Marquart HVH; Albertsen BK; Heyman M; Schmiegelow K
Eur J Haematol; 2018 Jan; 100(1):53-60. PubMed ID: 28983968
[TBL] [Abstract][Full Text] [Related]
15. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
16. Repeat-positive SARS-CoV-2 in a child with cancer.
Radhakrishnan V; Gangopadhyay D
Pediatr Blood Cancer; 2021 Mar; 68(3):e28744. PubMed ID: 33009874
[No Abstract] [Full Text] [Related]
17. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
Nygaard U; Toft N; Schmiegelow K
Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
[TBL] [Abstract][Full Text] [Related]
18. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
19. DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
Harju T; Hurme-Niiranen A; Suo-Palosaari M; Nygaard Nielsen S; Hinttala R; Schmiegelow K; Uusimaa J; Harila A; Niinimäki R
Pharmacogenomics J; 2023 Sep; 23(5):105-111. PubMed ID: 37138020
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of monoclonal, aggressive Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia.
Perkkiö M; Riikonen P; Seuri R; Vornanen M
Med Pediatr Oncol; 1999 Jun; 32(6):447-9. PubMed ID: 10358706
[No Abstract] [Full Text] [Related]
[Next] [New Search]